Candriam S.C.A. Boosts Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Candriam S.C.A. grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 13.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 110,949 shares of the real estate investment trust’s stock after acquiring an additional 12,966 shares during the quarter. Candriam S.C.A.’s holdings in Healthpeak Properties were worth $2,249,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of the company. State Street Corp bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth $1,093,576,000. JPMorgan Chase & Co. raised its stake in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after purchasing an additional 4,056,931 shares during the period. Principal Financial Group Inc. raised its stake in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after purchasing an additional 17,314,572 shares during the period. Geode Capital Management LLC bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth $403,898,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Healthpeak Properties by 0.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust’s stock worth $205,810,000 after purchasing an additional 53,392 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Up 1.9 %

Shares of NYSE DOC opened at $20.52 on Monday. Healthpeak Properties, Inc. has a 12 month low of $16.66 and a 12 month high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $14.35 billion, a price-to-earnings ratio of 58.62, a PEG ratio of 2.17 and a beta of 1.14. The business has a 50-day moving average of $20.20 and a 200-day moving average of $21.29.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.22 annualized dividend and a dividend yield of 5.95%. Healthpeak Properties’s payout ratio is presently 348.57%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on DOC shares. Mizuho lowered their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research note on Wednesday, January 15th. Robert W. Baird lowered their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Finally, Wells Fargo & Company lowered their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.